Sun Pharma’s Winning Formula: Precision Over Expansion
India’s largest drugmaker Sun Pharma has carved out its niche by focusing on unmet patient needs rather than chasing every new market segment, according to founder and executive chairman Dilip Shanghvi. Speaking at the IFQM Symposium, he stressed the company’s strategy of developing therapies with fewer side effects and improved delivery systems. With an annual R&D spend of $450 million, Sun Pharma’s portfolio spans dermatology, oncology, and ophthalmology. Its psoriasis drug Ilumya generated $681 million in FY25 sales, while new alopecia therapy Leqselvi is set to challenge Eli Lilly’s Olumiant with a higher-dosage regimen. Today, two-thirds of Sun Pharma’s revenue comes from international markets, underscoring its global shift since acquiring Ranbaxy for $4 billion in 2014 despite its troubled past. Shanghvi emphasized that setbacks never invalidate strategy: success lies in execution.
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-07-30
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Moldova Proposes Stricter Quality Standards for Edible Casein and Caseinates
-
China National Chemical Signs 2711 Contracts Worth 224.8 Billion Yuan by July Landmark Green Ammonia and Overseas Projects Highlighted
-
Steel in the Hourglass: Germany’s “Protect-Steel” Proposal and the Green Calculation Behind It
-
$20 Million Trinseo Polycarbonate Recycling Plant Lands in Zhangjiagang 5000 Ton Capacity to Power New Materials Boom
-
Xianda Reports 2561 Percent Net Profit Surge in H1 2025 Innovation and Overseas Markets Drive Explosive Growth
-
Sumitomo Chemical Unveils Breakthrough Pilot Plant for Direct Propylene from Ethanol Green Hydrogen as Byproduct
-
Hengyi Petrochemical H1 Revenue Reaches 55.96 Billion Yuan Profit Hits 227 Million as New Projects Accelerate
-
Indonesia Plans B50 Biodiesel Mandate for 2026 Palm Oil Usage May Hit 19 Million Kiloliters
-
Eco Refrigerants Market to Hit $2.3 Billion by 2032 Asia Pacific Leads with 7 Percent CAGR
-
China Energy Group Appoints Xu Xinfu as Board Director and Deputy Party Secretary Ranks 84th in Fortune Global 500
Recommend Reading
-
When Soybeans Lose Weight, Fertilizers Take the Stage: The Industrial Chain Reaction Behind U.S. Farm Subsidies
-
China's National Narcotics Control Commission Issues Important Notice: Beware of These 8 Chemicals Being Diverted for Drug Production
-
Arkema Triples Transparent Polyamide Capacity in Singapore: a Bet on Virtual Reality Growth or a Move to Strengthen Supply Resilience?
-
New York’s Food Chemical Disclosure Bill Raises the Bar for GRAS Transparency
-
Jell-O Simply Shows Clean Label Reformulation Has Entered Legacy Brands
-
Weak and Stagnant Ethanol Market Conditions in China
-
In August, China's BDO market continued to decline
-
Middle East Geopolitical Tensions Intensify, China's SC Crude Oil Futures See Significant Premium Over Brent and WTI
-
Cost-Driven Acrylic Acid Prices Fluctuate Higher
-
This week, the cyclohexane market in China mainly maintained stable operation (9.5-9.12)